HTG Molecular Diagnostics Inc. (HTGMQ)

Overview

HTG Molecular Diagnostics, Inc. is a pioneering life sciences company, dedicated to impacting the field of precision medicine. Focusing on the development of instruments, consumables, and software, the company excels at automating sample processing and profiling a diverse array of molecular targets. Despite its innovative contributions to molecular diagnostics and precision medicine, HTG Molecular Diagnostics faced significant financial challenges, leading to a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware on June 5, 2023. Established in 1997 and undergoing a name change from HTG, Inc. to HTG Molecular Diagnostics, Inc. in March 2011, the company is headquartered in Tucson, Arizona. It operates with a focus on serving the needs of biopharmaceutical companies, academic research centers, and molecular testing laboratories both in the United States and across the globe.

Products and Services

• HTG Transcriptome Panel

This comprehensive molecular profiling panel aids in the exploration of the genetic landscape, facilitating the discovery of novel biomarkers and the understanding of complex disease mechanisms.

• HTG EdgeSeq Precision Immuno-Oncology Panel

Designed for the burgeoning field of immuno-oncology, this panel enables in-depth analysis of the immune response to cancers, assisting in the development of personalized cancer therapies.

• HTG EdgeSeq miRNA Whole-Transcriptome Assay

This assay provides a detailed examination of miRNA expression levels across the entire transcriptome, offering insights into their roles in gene regulation and their potential as disease biomarkers.

• HTG EdgeSeq DLBCL Cell of Origin Assay EU

Specifically tailored for diffuse large B-cell lymphoma (DLBCL), this assay aids in classifying the cell of origin subtypes, crucial for prognosis and treatment strategy determination.

• HTG EdgeSeq Oncology Biomarker Panel

A versatile tool in the field of oncology, this panel supports the identification and quantification of biomarkers relevant to various cancers, enhancing targeted therapy approaches.

• HTG Immune Response Panel

This panel provides comprehensive insights into the immune system's response mechanisms, supporting research in immunology, vaccine development, and immune-oncology.

• HTG Mouse mRNA Tumor Response Panel

Catering to preclinical studies, this panel enables the evaluation of tumor response in mouse models, facilitating the translation of findings from lab to clinic in cancer research.